Brachytherapy for prostate cancer: feasible but oncological equivalence unproven

Publisher： John Wiley & Sons Inc

E-ISSN： 1464-410x|116|S3|89-91

ISSN： 1464-4096

Source： BJU INTERNATIONAL, Vol.116, Iss.S3, 2015-10, pp. : 89-91

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Brachytherapy for Prostate Cancer

By  

Urologia Internationalis, Vol. 63, Iss. 2, 1999-12 ,pp. : 87-91

Karger

Access to resources Recommend Favorite

Long‐term oncological outcomes and toxicity in 597 men aged ≤60 years at time of low‐dose‐rate brachytherapy for localised prostate cancer

By  

BJU INTERNATIONAL, Vol. 121, Iss. 1, 2018-01 ,pp. : 38-45

John Wiley & Sons Inc

Access to resources Recommend Favorite

Brachytherapy: state‐of‐the‐art radiotherapy in prostate cancer

By  

BJU INTERNATIONAL, Vol. 116, Iss. S3, 2015-10 ,pp. : 80-88

John Wiley & Sons Inc

Access to resources Recommend Favorite

Brachytherapy in prostate cancer: techniques and clinical outcomes

By  

TRENDS IN UROLOGY AND MEN'S HEALTH, Vol. 9, Iss. 1, 2018-01 ,pp. : 19-24

John Wiley & Sons Inc

Access to resources Recommend Favorite

The rise and fall of prostate brachytherapy: Use of brachytherapy for the treatment of localized prostate cancer in the National Cancer Data Base

By  

CANCER, Vol. 120, Iss. 14, 2014-07 ,pp. : 2114-2121

John Wiley & Sons Inc

Access to resources Recommend Favorite